Has This Medical Leader Hit Health Care's Biggest Jackpot?

Has This Medical Leader Hit Health Care's Biggest Jackpot?

Medtronic is the world's largest pure medical-device maker, but this stable stock has also impressed investors with amazing growth in 2013. Shares of the company are up more than 34% in 2013. Medtronic's a powerful player in the cardiology market and more, but this company's not just thinking in American sales -- it's thinking globally.

How big are we talking? Medtronic this week agreed to an investment with India's Apollo Hospitals Enterprise to develop a portable kidney dialysis device. It's the company's first venture into kidney dialysis, a market traditionally dominated by powers such as Fresenius Medical and others. But the real key for Medtronic and its investors is India, an emerging market rivaled by few other developing economies that could provide a new booming market in health care for decades to come.

Yet is Medtronic's investment in India a sign of more good things to come for investors? In the video below, Motley Fool contributor Dan Carroll tells you everything you need to know about Medtronic's latest big move -- and how breaking into India could be the growth catalyst to keep this medical device leader on top for the long run.

Your guide to long-term financial success
Medtronic's been one of health care's top names over the years, and this solid stock is a testament to the greatest investing strategy around the markets: Investing for the long run is the easiest route to maximizing your portfolio's potential. The Motley Fool's special free report "3 Stocks That Will Help You Retire Rich" names specific investment opportunities that could help you build long-term wealth and help you retire well. The Fool also outlines critical wealth-building strategies that every investor should know. Click here to keep reading.

The article Has This Medical Leader Hit Health Care's Biggest Jackpot? originally appeared on Fool.com.

Fool contributor Dan Carroll has no position in any stocks mentioned. The Motley Fool recommends Baxter International. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published